Q - Acadia Healthcare Company,
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
ACHC$38.64+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity (Unaudited)
Condensed Consolidated Statements of Equity
(In thousands)
| Common Stock · AdditionalPaid-in · Retained | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount · Capital · Earnings · Total | ||||||
| Balance at December 31, 2023 | 91,264 | $913 | $2,649,340 | $131,721 | $2,781,974 | |
| Common stock issued under stock incentive plans | 310 | 3 | 4,099 | — | 4,102 | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (5,115) | — | (5,115) | |
| Equity-based compensation expense | — | — | 8,678 | — | 8,678 | |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 76,383 | 76,383 | |
| Balance at March 31, 2024 | 91,574 | 916 | 2,657,002 | 208,104 | 2,866,022 | |
| Common stock issued under stock incentive plans | 107 | 1 | 1,477 | — | 1,478 | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (2,133) | — | (2,133) | |
| Equity-based compensation expense | — | — | 8,869 | — | 8,869 | |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 78,482 | 78,482 | |
| Balance at June 30, 2024 | 91,681 | 917 | 2,665,215 | 286,586 | 2,952,718 | |
| Common stock issued under stock incentive plans | 76 | 1 | 1,608 | — | 1,609 | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (765) | — | (765) | |
| Equity-based compensation expense | — | — | 9,467 | — | 9,467 | |
| Other | — | — | 357 | 357 | ||
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 68,132 | 68,132 | |
| Balance at September 30, 2024 | 91,757 | 918 | 2,675,882 | 354,718 | 3,031,518 | |
| Common stock issued under stock incentive plans | 18 | — | 21 | — | 21 | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (538) | — | (538) | |
| Equity-based compensation expense | — | — | 10,099 | — | 10,099 | |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 32,615 | 32,615 | |
| Balance at December 31, 2024 | 91,775 | 918 | 2,685,464 | 387,333 | 3,073,715 | |
| Common stock issued under stock incentive plans | 217 | 2 | (2) | — | — | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (1,936) | — | (1,936) | |
| Repurchase of common stock | (1,603) | (16) | — | (47,256) | (47,272) | |
| Equity-based compensation expense | — | — | 8,677 | — | 8,677 | |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 8,374 | 8,374 | |
| Balance at March 31, 2025 | 90,389 | 904 | 2,692,203 | 348,451 | 3,041,558 | |
| Common stock issued under stock incentive plans | 109 | 1 | (1) | — | — | |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (1,780) | — | (1,780) | |
| Repurchase of common stock | (104) | (1) | — | (3,159) | (3,160) | |
| Equity-based compensation expense | — | — | 10,549 | — | 10,549 | |
| Other | — | — | 692 | — | 692 | |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 30,127 | 30,127 | |
| Balance at June 30, 2025 | 90,394 | $904 | $2,701,663 | $375,419 | $3,077,986 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.